Papers

28

Total Citations

1,164

H-Index

15

About

Brent K. Hollenbeck is a leading urologic oncologist and health services researcher whose work has fundamentally shaped the understanding of surgical quality, cost, and outcomes in prostate and bladder cancer care. His research centers on the comparative effectiveness of robotic versus open surgical techniques, the dissemination of advanced treatment technologies, and the critical role of surgeon volume in patient outcomes. Hollenbeck’s landmark study on the International Robotic Cystectomy Consortium (over 300 citations) demonstrated the feasibility and safety of intracorporeal urinary diversion, while his highly cited analysis of advanced treatment technologies (141 citations) exposed the troubling trend of overtreatment among low-risk prostate cancer patients. He has also produced seminal work on the costs of radical prostatectomy and the risk factors for post-surgical complications, such as vesicourethral anastomotic stenoses. With multiple papers exceeding 100 citations and a consistent focus on real-world, population-based outcomes, Hollenbeck’s research provides the evidence base for value-driven surgical decision-making. His contributions are essential reading for anyone interested in the intersection of surgical innovation, health policy, and patient-centered outcomes.

Research Focus

Key Achievements

15
H-Index
28
Papers
1,164
Total Citations
42
Avg Citations/Paper
🏆 Most Cited Paper
Analysis of Intracorporeal Compared with Extracorporeal Urinary Diversion After Robot-assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium
307 citations · 2013
📈 Most Prolific Year: 2013 (6 Papers)
🤝 Key Collaborators: 117
🏛 Institutions: Michigan Medicine, University of Michigan–Ann Arbor, Ann Arbor Center for Independent Living

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago